Invest now
Blue Jet Healthcare share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹520.80(0.09%)October 16, 2026 15:25:52 PM IST
- NSE
- BSE
- Vol : 147.94 K (NSE + BSE)Last 20 day avg : 395.71 K
Blue Jet Healthcare is trading 0.09% upper at Rs 520.80 as compared to its last closing price. Blue Jet Healthcare has been trading in the price range of 525.05 & 516.60. Blue Jet Healthcare has given -2.03% in this year & 0.17% in the last 5 days. Blue Jet Healthcare has TTM P/E ratio 38.77 as compared to the sector P/E of 33.15.There are 6 analysts who have initiated coverage on Blue Jet Healthcare. There are 3 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 78.26 Crores in its last quarter.Listed peers of Blue Jet Healthcare include Sun Pharmaceutical Industries (-0.03%), Divi's Laboratories (1.99%), Torrent Pharmaceuticals (-1.00%).The Mutual Fund holding in Blue Jet Healthcare was at 4.10% in 30 Sep 2026. The MF holding has decreased from the last quarter. The FII holding in Blue Jet Healthcare was at 0.81% in 30 Sep 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 16 Oct 2026, 05:58 PM IST
- Debt To EquityLower than industry0.03The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.23Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation2.46The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Blue Jet Healthcare News
Blue Jet Healthcare Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,760.00 | -0.03 | 4,22,273.00 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,220.00 | 1.99 | 2,44,762.03 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,560.00 | -1.00 | 1,73,441.54 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,325.00 | -0.65 | 1,07,041.24 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,124.30 | -1.44 | 1,12,149.36 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allBlue Jet Healthcare Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-25 | Audited Results, Dividend & Fund Raising |
| 2026-02-13 | Quarterly Results |
| 2025-11-04 | Quarterly Results |
| 2025-07-22 | Quarterly Results |
About the company Blue Jet Healthcare
- IndustryBiotechnology & Drugs
- ISININE0KBH01020
- BSE Code544009
- NSE CodeBLUEJET
Blue Jet Healthcare Limited is an India-based company. The Company is engaged in the business of manufacturing artificial sweeteners, contrast media intermediates, pharma intermediate, active pharmaceutical ingredients (APIs) used in pharmaceutical and healthcare products. It serves as a business-to-business company. Its integrated contrast media intermediate portfolio includes advanced intermediates for both iodine-based contrast agents used in X-ray and CT imaging, as well as gadolinium-based contrast agents used in MRI diagnostics. It manufactures saccharin and supplies to the healthcare, pharma, animal feed, food and beverages industries globally. It offers end-to-end integrated solutions from process development to commercialization of NCEs, advance intermediates, APIs and building blocks. Its expertise in Amino Acid-based derivatives develops and manufactures them on a small scale and is in the process of building multi-modular production blocks for large-scale manufacturing.
Blue Jet Healthcare Share Price FAQs
Blue Jet Healthcare is trading at 520.80 as on Fri Oct 16 2026 09:55:52. This is 0.09% upper as compared to its previous closing price of 520.35.
The market capitalization of Blue Jet Healthcare is 9857.48 Cr as on Fri Oct 16 2026 09:55:52.
The average broker rating on Blue Jet Healthcare is Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 1 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Blue Jet Healthcare is 688.00 whereas the 52 wk low is 325.20
Blue Jet Healthcare can be analyzed on the following key metrics -
- TTM P/E: 38.77
- Sector P/E: 33.15
- Dividend Yield: 0.23%
- D/E ratio: -
Blue Jet Healthcare reported a net profit of 247.82 Cr in 2026.
The Mutual Fund Shareholding was 4.10% at the end of 30 Sep 2026.
Quick Links
EQUITY QUICK LINKS
Blue Jet Healthcare QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.